Rituximab in IgG4-RD: A Phase 1-2 Trial

Clinical trial NCT01584388 · COMPLETED

Trial details

NCT number: NCT01584388
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Retroperitoneal Fibrosis Autoimmune Pancreatitis Sialadenitis Pseudotumor

Start date: 2012-04-01
Primary completion: 2014-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.